| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S10741-009-9143-0 |
| P698 | PubMed publication ID | 19404737 |
| P50 | author | Faiez Zannad | Q19631268 |
| Patrick Rossignol | Q33103963 | ||
| Wafae Iraqi | Q125201281 | ||
| P2860 | cites work | Arterial stiffness and extracellular matrix | Q28271222 |
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 | ||
| Extracellular matrix proteins in cardiac fibroblasts derived from rat hearts with chronic pressure overload: effects of beta-receptor blockade | Q31952569 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Alteration of collagen phenotypes in ischemic cardiomyopathy | Q34203398 | ||
| Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship. | Q34441567 | ||
| Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction | Q34635631 | ||
| Remodeling of the myocardium and potential targets in the collagen degradation and synthesis pathways | Q35137466 | ||
| Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? | Q35219500 | ||
| Relation between plasma amino-terminal propeptide of procollagen type III and left ventricular longitudinal strain in essential hypertension | Q35584082 | ||
| Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms | Q35747748 | ||
| Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications. | Q35936620 | ||
| Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure | Q36158058 | ||
| The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease | Q36186361 | ||
| Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects | Q36583152 | ||
| Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls | Q36656424 | ||
| Mechanisms of cardiac fibrosis in hypertension | Q36873139 | ||
| Left ventricular hypertrophy and geometry in untreated essential hypertension is associated with blood levels of aldosterone and procollagen type III amino-terminal peptide | Q80211596 | ||
| Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats | Q83190392 | ||
| Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease | Q83195156 | ||
| Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. | Q37085417 | ||
| Collagen turnover and its regulation in the normal and hypertrophying heart | Q40412418 | ||
| Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects | Q40477189 | ||
| Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation | Q41665154 | ||
| High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients | Q43589861 | ||
| Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats | Q43593701 | ||
| Cardiac remodeling after long term norepinephrine treatment in rats. | Q43782715 | ||
| Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients | Q44009234 | ||
| TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension | Q44087061 | ||
| Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard | Q44430971 | ||
| Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study | Q44601096 | ||
| Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial. | Q44995481 | ||
| Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis | Q45020454 | ||
| Collagen expression in mechanically stimulated cardiac fibroblasts | Q45127467 | ||
| Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stu | Q46034385 | ||
| Clinical significance of matrix metalloproteinases activity in acute myocardial infarction | Q46533086 | ||
| Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance | Q46664447 | ||
| Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes | Q46731184 | ||
| Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study | Q46795039 | ||
| Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency | Q47300528 | ||
| Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction | Q48155813 | ||
| Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction | Q48265113 | ||
| Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure | Q48482082 | ||
| Collagen metabolism in extracellular matrix may be involved in arterial stiffness in older hypertensive patients with left ventricular hypertrophy. | Q51212140 | ||
| Residual stress ischaemia is associated with blood markers of myocardial structural remodelling. | Q53510180 | ||
| Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. | Q53578883 | ||
| Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension. | Q53702216 | ||
| Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure | Q57259661 | ||
| Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) | Q57395347 | ||
| Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure | Q57396283 | ||
| MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition | Q58402470 | ||
| Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease | Q61687971 | ||
| Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium | Q68428629 | ||
| Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats | Q68433121 | ||
| Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction | Q68697994 | ||
| Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis | Q70993068 | ||
| Role of specimen collection in preanalytical variation of metalloproteinases and their inhibitors in blood | Q71904693 | ||
| Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis | Q72198058 | ||
| Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations | Q72571565 | ||
| Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats | Q72710459 | ||
| [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling] | Q73247498 | ||
| Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction | Q73624332 | ||
| Monitoring tissue repair and fibrosis from a distance | Q73841580 | ||
| Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction | Q74012895 | ||
| Ontogeny of enhanced decorin levels and distribution within myocardium of failing hearts | Q74614146 | ||
| Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats | Q74662527 | ||
| Abnormalities of the extracellular degradation of collagen type I in essential hypertension | Q77133088 | ||
| Time-dependent changes of serum carboxy-terminal peptide of type I procollagen and carboxy-terminal telopeptide of type I collagen concentrations in patients with acute myocardial infarction after successful reperfusion: correlation with left ventri | Q77628985 | ||
| Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia | Q79448254 | ||
| P433 | issue | 4 | |
| P921 | main subject | heart failure | Q181754 |
| extracellular matrix | Q193825 | ||
| P304 | page(s) | 319-329 | |
| P577 | publication date | 2010-07-01 | |
| P1433 | published in | Heart Failure Reviews | Q2167497 |
| P1476 | title | Extracellular matrix fibrotic markers in heart failure | |
| P478 | volume | 15 |
| Q35061221 | Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle |
| Q38662968 | Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment. |
| Q38552038 | Cardiac extracellular matrix proteomics: Challenges, techniques, and clinical implications |
| Q38040163 | Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease |
| Q40286144 | Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation |
| Q37441111 | Comparative mRNA and MicroRNA Profiling during Acute Myocardial Infarction Induced by Coronary Occlusion and Ablation Radio-Frequency Currents |
| Q37391940 | Coronary collaterals predict improved survival and allograft function in patients with coronary allograft vasculopathy |
| Q35161745 | Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase |
| Q54990315 | Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis. |
| Q37451582 | Gene Expression Profiles of Peripheral Blood Mononuclear Cells Reveal Transcriptional Signatures as Novel Biomarkers for Cardiac Remodeling in Rats with Aldosteronism and Hypertensive Heart Disease |
| Q38677735 | Induction of cardiac dysfunction in developing and adult zebrafish by chronic isoproterenol stimulation |
| Q47644833 | Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide vs. furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial). |
| Q47136571 | MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis |
| Q57298801 | Myocardial collagen turnover after surgical ventricular restoration in heart failure patients |
| Q39195672 | Pathophysiological Fundamentals of Diabetic Cardiomyopathy |
| Q60017083 | Perivascular fibrosis and the microvasculature of the heart. Still hidden secrets of pathophysiology? |
| Q38062031 | Personalizing biomarker strategies in heart failure with galectin-3. |
| Q55434646 | Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi-Ethnic Study of Atherosclerosis). |
| Q36085814 | Procollagen C-Proteinase Enhancer 1 (PCPE-1) as a Plasma Marker of Muscle and Liver Fibrosis in Mice |
| Q36992872 | Relaxin Level in Patients With Atrial Fibrillation and Association with Heart Failure Occurrence: A STROBE Compliant Article |
| Q41810657 | STOP-HF: Expanding the role of HF programs into the community |
| Q37314530 | Secondhand Smoke Exposure Enhances Cardiac Fibrosis Effects on the Aging Rat Hearts. |
| Q28066160 | Systems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrix |
| Q54174170 | The p66ShcA adaptor protein regulates healing after myocardial infarction. |
| Q37895982 | Tissue inhibitor of metalloproteinases (TIMPs) in heart failure |
| Q91327384 | Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology |
| Q36086794 | Towards organ printing: engineering an intra-organ branched vascular tree |
| Q35740866 | Vitamin D receptor genetics on extracellular matrix biomarkers and hemodynamics in systolic heart failure. |
Search more.